- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cresco Labs announced it was approved for an upgrade to the OTCQX Best Market.
Cresco Labs (CSE:CL,OTCQX:CRLBF) announced it was approved for an upgrade to the OTCQX Best Market.
As quoted in the press release:
Cresco Labs’ stock, which started being quoted on the OTC on March 6, 2019, will continue to trade under the symbol “CRLBF.”
“Being upgraded to the OTCQX Best Market represents another important milestone for Cresco Labs and reflects our commitment to adhering to high standards of compliance, disclosure and corporate governance,” said Cresco Labs CEO and Co-founder Charlie Bachtell. “We believe that listing on the OTCQX will open up our stock to a larger universe of potential investors. With increased liquidity and better exposure to U.S. investors, we believe the move to the OTCQX will be beneficial to both new and existing shareholders.”
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.